Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus

December 14, 2020 updated by: GULIN FINDIKOGLU, Pamukkale University
The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on metabolic parameters, physical measures, fitness level, body composition and miRNA-143 level in patients with type 2 diabetes mellitus.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise which is in the form of high intensity interval exercise 2.group will make aerobic exercise which is in the form of moderate intensity continuous exercise 3. Control group. Exercise groups will be cycling under observation in the hospital setting. Control group will make simple stretching exercises at home. Participants will be requested to complete a 3 months of exercise. They will be evaluated before and at the end of the 3 months of exercise with physical measures such as waist and hip circumference, fitness level measured by exercise testing, body composition measured by bioimpedance, metabolic parameters such as blood glucose level, HbA1C and measured by blood tests.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Denizli, Turkey, 21600
        • Pamukkale University
      • Denizli, Turkey, 20100
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants must have type 2 Diabetes mellitus less than 10 years and more than 1 year.
  2. Participants must have appropriate medical therapy and diet.
  3. Participants must not be treated with insulin.
  4. Participants must be exercising less than 210 minutes/ week.

Exclusion Criteria:

  1. Participants with prominent cardiovascular disease
  2. Participants with coronary artery disease
  3. Participants with moderate to severe valvular disease
  4. Participants with atrial fibrillation
  5. Participants with untreated hypertension
  6. Participants with congenital heart disease
  7. Participants with retinopathy
  8. Participants with neuropathy
  9. Participants with macro albuminuria
  10. Participants with cerebrovascular disease
  11. Participants with ejection fraction less than 40
  12. Participants with body mass index greater than 35.
  13. Participants with prominent ischemic changes in EKG at rest or during exercise.
  14. Participants with cigarette or alcohol addiction
  15. Participants on drugs that interferes with body fat distribution (such as insulin, thiazolidinediones)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: High intensity interval exercise
Participants with type 2 Diabetes mellitus in High intensity interval exercise (HIIE) group will make aerobic exercise using bicycle at high intensity followed by low intensity periods under observation in the hospital.
Aerobic tyep of exercise will be made at different intensities in 2 groups.
Active Comparator: Moderate intensity continuous exercise
Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.
Aerobic tyep of exercise will be made at different intensities in 2 groups.
No Intervention: Control group
The participants in the control group will make stretching exercise at home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HbA1c level.
Time Frame: 12 weeks
Change in HbA1c level measured in the blood after exercise compared to beginning
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: GULIN FINDIKOGLU, Assoc Prof, Pamukkale University, Medical Faculty, PMR Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2019

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 14, 2020

Study Registration Dates

First Submitted

September 21, 2018

First Submitted That Met QC Criteria

September 21, 2018

First Posted (Actual)

September 24, 2018

Study Record Updates

Last Update Posted (Actual)

December 16, 2020

Last Update Submitted That Met QC Criteria

December 14, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on exercise

Subscribe